A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway.
- DOI
- 10.1016/j.csbj.2021.05.003
- Published
- 2021
- Container
- Computational and structural biotechnology journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.csbj.2021.05.003,
title = {A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway.},
author = {Wei R and Wu Q and Ai N and Wang L and Zhou M and Shaw C and Chen T and Ye RD and Ge W and Siu SWI and Kwok HF},
year = {2021},
journal = {Computational and structural biotechnology journal},
doi = {10.1016/j.csbj.2021.05.003},
url = {https://doi.org/10.1016/j.csbj.2021.05.003}
}RIS
TY - JOUR TI - A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway. AU - Wei R AU - Wu Q AU - Ai N AU - Wang L AU - Zhou M AU - Shaw C AU - Chen T AU - Ye RD AU - Ge W AU - Siu SWI AU - Kwok HF PY - 2021 JO - Computational and structural biotechnology journal DO - 10.1016/j.csbj.2021.05.003 UR - https://doi.org/10.1016/j.csbj.2021.05.003 ER -
APA
R, W., Q, W., N, A., L, W., M, Z., C, S., T, C., RD, Y., W, G., SWI, S., & HF, K. (2021). A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway.. Computational and structural biotechnology journal. https://doi.org/10.1016/j.csbj.2021.05.003
Source records
- pubmed · retrieved 2026-09-27T11:23:47.874Z